论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
病例报告:血液中宏基因组下一代测序诊断隐孢子虫引起的严重腹泻
Authors Shan H, Wei C, Zhang J, He M, Zhang Z
Received 24 May 2023
Accepted for publication 23 August 2023
Published 1 September 2023 Volume 2023:16 Pages 5777—5782
DOI https://doi.org/10.2147/IDR.S422799
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Suresh Antony
Background: Cryptosporidium is one of the major pathogens causing diarrhea worldwide. At present, cryptosporidiosis is difficult to prevent and control, especially in immunocompromised hosts. It may cause life-threatening diarrhea and malabsorption among children and immunocompromised patients. Therefore, it is very important to explore rapid diagnostic tools and treatment methods for Cryptosporidium infection.
Case Presentation: We reported a case of severe diarrhea caused by cryptosporidiosis in a liver transplant recipient, whose condition was finally confirmed by metagenomic next-generation sequencing (mNGS) and fecal microscopy. His illness was resolved with immunosuppression regulation, nitazoxanide administration, and infection control.
Conclusion: So far, nitazoxanide is still the first choice for the treatment of cryptosporidiosis. Our institutional experience suggested that nitazoxanide alone may be effective on the basis of adjusting immunosuppressant. In addition, even though diagnosis of Cryptosporidium infection is a challenge, mNGS can serve as a rapid screening tool in low-prevalence setting.
Keywords: nitazoxanide, cryptosporidiosis, Cryptosporidium , transplant recipient, azithromycin